We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.54B
AUM Growth
+$237M
Cap. Flow
-$26.5M
Cap. Flow %
-0.58%
Top 10 Hldgs %
16.93%
Holding
607
New
39
Increased
188
Reduced
275
Closed
42

Top Sells

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$16M
2
AGN
Allergan plc
AGN
+$15.1M
3
BFH icon
Bread Financial
BFH
+$14.7M
4
TECH icon
Bio-Techne
TECH
+$14M
5
DIS icon
Walt Disney
DIS
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 17.45%
2 Industrials 16.76%
3 Financials 14.5%
4 Technology 13.57%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
326
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$1.35M 0.03%
3,913
EW icon
327
Edwards Lifesciences
EW
$47.6B
$1.29M 0.03%
34,296
+411
+1% +$15.1K
NXPI icon
328
NXP Semiconductors
NXPI
$68B
$1.25M 0.03%
10,665
-1,175
-10% -$136K
CL icon
329
Colgate-Palmolive
CL
$72.6B
$1.24M 0.03%
16,380
+44
+0.3% +$3.21K
LBTYK icon
330
Liberty Global Class C
LBTYK
$3.27B
$1.23M 0.03%
36,262
-2,000
-5% -$61.4K
BAC icon
331
Bank of America
BAC
$435B
$1.23M 0.03%
41,490
+433
+1% +$11.9K
TYL icon
332
Tyler Technologies
TYL
$12.2B
$1.22M 0.03%
+6,885
New +$1.22M
EEM icon
333
iShares MSCI Emerging Markets ETF
EEM
$28.5B
$1.22M 0.03%
25,793
-800
-3% -$37K
MON
334
DELISTED
Monsanto Co
MON
$1.17M 0.03%
10,034
RDS.A
335
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.15M 0.03%
17,303
+1,878
+12% +$118K
EPC icon
336
Edgewell Personal Care
EPC
$1.27B
$1.14M 0.03%
19,204
-76,364
-80% -$4.8M
BP icon
337
BP
BP
$113B
$1.1M 0.02%
28,670
+1,198
+4% +$43.4K
MA icon
338
Mastercard
MA
$477B
$1.1M 0.02%
7,290
+853
+13% +$127K
AZO icon
339
AutoZone
AZO
$48.3B
$1.1M 0.02%
1,542
+2
+0.1% +$1.28K
MD icon
340
Pediatrix Medical
MD
$2.16B
$1.07M 0.02%
20,050
-321
-2% -$15.1K
XEL icon
341
Xcel Energy
XEL
$51B
$1.05M 0.02%
21,805
-30
-0.1% -$1.49K
INGR icon
342
Ingredion
INGR
$6.38B
$1.04M 0.02%
7,434
-779
-9% -$103K
VUG icon
343
Vanguard Growth ETF
VUG
$216B
$1.02M 0.02%
43,572
-19,920
-31% -$457K
WEN icon
344
Wendy's
WEN
$1.33B
$1.02M 0.02%
62,017
-16,405
-21% -$249K
GILD icon
345
Gilead Sciences
GILD
$161B
$998K 0.02%
13,927
-6,551
-32% -$497K
ACC
346
DELISTED
American Campus Communities, Inc.
ACC
$992K 0.02%
24,173
-7,822
-24% -$334K
TSM icon
347
TSMC
TSM
$2.09T
$986K 0.02%
24,859
+7,010
+39% +$284K
AZPN
348
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$980K 0.02%
14,802
IWV icon
349
iShares Russell 3000 ETF
IWV
$19.4B
$978K 0.02%
6,183
+1,814
+42% +$280K
GD icon
350
General Dynamics
GD
$105B
$973K 0.02%
4,782
+229
+5% +$46.8K

Similar funds

Segall Bryant & Hamill's Q4 2017 Portfolio in Review

As of Q4 2017, Segall Bryant & Hamill held 607 positions worth $4.54B, up 5.5% from $4.31B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Segall Bryant & Hamill's Q4 2017 filing shows 39 new, 188 increased, 275 reduced and 42 closed positions. Its largest new stake was Black Knight, Inc. Common Stock: 320,006 shares worth $14.1M. The largest sale was Newell Brands, an estimated $16M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q4 2017 buy was Black Knight, Inc. Common Stock: 320,006 shares worth $14.1M.
  • Segall Bryant & Hamill added most to FLIR Systems, Inc. (DE) Common Stock in Q4 2017, an estimated $46.2M increase.
  • Segall Bryant & Hamill's biggest Q4 2017 reduction was Newell Brands, cutting an estimated $16M.
  • Segall Bryant & Hamill fully exited Gigamon Inc. in Q4 2017, selling an estimated $8.49M.
  • Segall Bryant & Hamill's ten largest holdings make up 17% of its $4.54B portfolio in Q4 2017.
  • Segall Bryant & Hamill opened 39 new positions and closed 42 in Q4 2017.
  • Segall Bryant & Hamill's portfolio value rose 5.5% quarter-over-quarter to $4.54B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2017, filed 15 Feb 2018.